Tafalgie Therapeutics (private company)

Tafalgie Therapeutics is a biotech startup in France developing non-opioid treatments for pain - next-generation analgesics that modulate pain signals through TAFA4 protein-derived compounds. Its aim is to address acute, chronic, neuropathic, inflammatory, and post-operative pain without the risks associated with conventional painkillers such as respiratory issues, sedation, tolerance, and addiction.